TP53 and glioblastoma: Another path was the transdifferentiation of CSCs, which was groundbreakingly reported in glioblastoma, from an accidental discovery of p53 alterations in endothelial cells of glioblastoma capillaries, indicating that a significant portion of the vascular endothelium has a neoplastic origin [92].